You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藥明康德(603259.SH):公司始終在接受強監管的醫藥健康行業中穩健運營

格隆匯6月11日丨藥明康德(603259.SH)在互動平臺表示,正如公司在說明會上表達的那樣,我們注意到,最近美國新興生物技術國家安全委員會報告有若幹涉及公司的毫無根據的指稱。公司此前已公開說明,公司從沒有過任何未經授權將美國客戶的數據或知識產權轉移給第三方的情況。我們也已就此與美國相關政府機構進行了溝通以澄清事實。 藥明康德是一家公衆上市公司,有着透明的公司治理體系。公司沒有與任何政黨、政府或其軍事組織存在特殊關聯。過去二十多年來,公司始終在接受強監管的醫藥健康行業中穩健運營。公司一向嚴格遵守各地的法律法規,定期接受全球客戶以及美國和其他國家多家監管機構的監督與檢查,並且一直保持着卓越的合規審計和質量審計記錄。公司將繼續堅持一貫的首要任務——賦能全球客戶,持續助力醫藥和生命科學領域的創新突破,爲全球患者謀福祉。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account